- Home
- TRUP vs ATAI Comparison
TRUP vs ATAI Comparison
Compare TRUP & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRUP | ATAI |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TRUP | ATAI |
|---|---|---|
| Price | $37.92 | $3.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $56.33 | $14.00 |
| AVG Volume (30 Days) | 436.0K | ★ 3.0M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,399,759,000.00 | $3,018,000.00 |
| Revenue This Year | $14.02 | $943.83 |
| Revenue Next Year | $9.35 | N/A |
| P/E Ratio | $106.38 | ★ N/A |
| Revenue Growth | 12.50 | ★ 811.78 |
| 52 Week Low | $31.00 | $1.15 |
| 52 Week High | $57.89 | $6.75 |
Technical Indicators
Market Signals| Indicator | TRUP | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 41.30 |
| Support Level | $36.25 | $3.88 |
| Resistance Level | $38.70 | $4.33 |
| Average True Range (ATR) | 1.26 | 0.23 |
| MACD | 0.39 | 0.02 |
| Stochastic Oscillator | 79.89 | 15.82 |
Price Performance
Historical ComparisonAbout TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.